5 articles tagged with #breast-cancer. AI-curated summaries with sentiment analysis and key takeaways from 50+ sources.
MammoExpert introduces the first large-scale mammography dataset with Chain-of-Thought reasoning annotations, comprising 2,379 images across 67 histopathology subtypes. The dataset demonstrates significant improvements in breast lesion classification accuracy (4-7.1% gains) and provides a benchmark for interpretable AI diagnostic reasoning in medical imaging.
CRISP is an unsupervised machine learning framework that automates the analysis of multiple whole-slide images (WSIs) in digital pathology by selectively sampling informative patches across all slides in a case rather than relying on a single pathologist-selected slide. The approach matches or exceeds current clinical practice for breast cancer diagnosis and retrieval while eliminating subjective slide selection and reducing computational burden.
The MAMA-MIA Challenge introduced a large-scale benchmark for AI-powered breast cancer tumor segmentation and treatment response prediction using MRI data from 1,506 US patients for training and 574 European patients for testing. Results from 26 international teams revealed significant performance variability and trade-offs between accuracy and fairness across demographic subgroups when AI models were tested across different institutions and continents.
Researchers developed BUSD-Agent, an AI framework for breast cancer screening that uses cascaded agents and experience-guided decision-making to reduce unnecessary biopsies. The system achieved a 22% reduction in biopsy referrals while improving diagnostic accuracy through retrieval-based learning from past cases.
Researchers developed a new multi-task AI framework for breast ultrasound analysis that simultaneously performs lesion segmentation and tissue classification. The system uses multi-level decoder interaction and uncertainty-aware coordination to achieve 74.5% lesion IoU and 90.6% classification accuracy on the BUSI dataset.
